Journey Medical Corp Proceeds from Lines of Credit
Journey Medical Corp (DERM) reported Proceeds from Lines of Credit of $28.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2025-03-27
- Journey Medical Corp proceeds from lines of credit for the quarter ending 2023-12-31 was $0.00.
- Journey Medical Corp proceeds from lines of credit for the quarter ending 2023-09-30 was $0.00.
- Journey Medical Corp proceeds from lines of credit for the quarter ending 2023-06-30 was $0.00.
- Journey Medical Corp proceeds from lines of credit for the quarter ending 2023-03-31 was $28.00M.
- Journey Medical Corp proceeds from lines of credit for fiscal 2023 was $28.00M, a 460.00% increase from fiscal 2022.
- Journey Medical Corp proceeds from lines of credit for fiscal 2022 was $5.00M, a 28.57% decline from fiscal 2021.
- Journey Medical Corp proceeds from lines of credit for fiscal 2021 was $7.00M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | $28.00M 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $28.00M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $28.00M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $28.00M 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $5.00M 10-K · filed 2024-03-29 | |||
| 2021-12-31 | $7.00M 10-K · filed 2023-03-31 |